Rosemary J Huggins

3PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Sep 24, 2026
Integrative pipeline to profile and target endocrine therapy-insensitive cell populations in ER+ breast cancer.

|Nov 30, 2023
ERα/PR crosstalk is altered in the context of the ERα Y537S mutation and contributes to endocrine therapy-resistant tumor proliferation.

Rosemary J Huggins, Geoffrey L Greene

|May 28, 2022
Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells.

Purab Pal, Alec Millner, Svetlana E Semina

Pageof 1

Frequent Collaborators

2 joint publications

Geoffrey L Greene

1 joint publications

Purab Pal

1 joint publications

Alec Millner

1 joint publications

Svetlana E Semina

1 joint publications

Keiko Yanagihara

1 joint publications

Andre A Kajdacsy-Balla

1 joint publications

Debra A Tonetti

1 joint publications

Kent F Hoskins

1 joint publications

Jonna Frasor

Frequent Collaborators

2 joint publications

Geoffrey L Greene

1 joint publications

Purab Pal

1 joint publications

Alec Millner

1 joint publications

Svetlana E Semina

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us